[go: up one dir, main page]

BR9713562A - Fenil glioxamidas como inibidores de spla2 - Google Patents

Fenil glioxamidas como inibidores de spla2

Info

Publication number
BR9713562A
BR9713562A BR9713562-3A BR9713562A BR9713562A BR 9713562 A BR9713562 A BR 9713562A BR 9713562 A BR9713562 A BR 9713562A BR 9713562 A BR9713562 A BR 9713562A
Authority
BR
Brazil
Prior art keywords
phenyl
glyoxamides
spla2 inhibitors
inhibitors
spla
Prior art date
Application number
BR9713562-3A
Other languages
English (en)
Inventor
Theodore Junior Goodson
Richard Waltz Harper
David Kent Herron
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9713562A publication Critical patent/BR9713562A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)

Abstract

Patente de Invenção: <B>"FENIL GLIOXAMIDAS COMO INIBIDORES DE SPLA~ 2~"<D>. é apresentada uma classe de novas fenil glioxamidas, junto com o uso desses compostos para inibir a liberação de ácidos graxos mediada por sPLA~ 2~ para tratamento de condições tais como choque séptico.
BR9713562-3A 1996-12-03 1997-11-25 Fenil glioxamidas como inibidores de spla2 BR9713562A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3250996P 1996-12-03 1996-12-03
PCT/US1997/021434 WO1998024794A1 (en) 1996-12-03 1997-11-25 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS

Publications (1)

Publication Number Publication Date
BR9713562A true BR9713562A (pt) 2001-06-19

Family

ID=21865305

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713562-3A BR9713562A (pt) 1996-12-03 1997-11-25 Fenil glioxamidas como inibidores de spla2

Country Status (13)

Country Link
US (1) US5916922A (pt)
EP (1) EP0944636B1 (pt)
JP (1) JP2001505882A (pt)
KR (1) KR20000069249A (pt)
AT (1) ATE234850T1 (pt)
AU (1) AU5454498A (pt)
BR (1) BR9713562A (pt)
CA (1) CA2274019A1 (pt)
DE (1) DE69720034T2 (pt)
ES (1) ES2195182T3 (pt)
HU (1) HUP9904218A2 (pt)
IL (1) IL130201A0 (pt)
WO (1) WO1998024794A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407104B1 (en) 1998-03-31 2002-06-18 Shionogi & Co., Ltd. Pyrrolo[1,2-a]pyrazine spla2 inhibitor
CN1302300A (zh) 1998-05-21 2001-07-04 盐野义制药株式会社 吡咯并[1,2-b]哒嗪sPLA2抑制剂
ATE347362T1 (de) 1998-06-30 2006-12-15 Lilly Co Eli Bicyclische spla 2-inhibitoren
US7098237B1 (en) 1998-10-14 2006-08-29 Shionogi & Co., Ltd. Remedies for ischemia reperfusion injury
AU6015600A (en) 1999-07-19 2001-02-05 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
AU6023200A (en) 1999-08-02 2001-02-19 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
US7026318B2 (en) 2000-06-29 2006-04-11 Shionogi & Co., Ltd. Compounds exhibiting X-type sPLA2 inhibiting effect
AU2001267825A1 (en) 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Remedies for cirrhosis
TWI314457B (pt) 2001-03-19 2009-09-11 Shionogi & Co
US20120093922A1 (en) 2009-04-29 2012-04-19 Amarin Corporation Plc Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN102631449B (zh) * 2012-05-18 2013-09-11 崔新明 一种治疗急性胰腺炎的中药组合物
IT201800003040A1 (it) * 2018-02-26 2019-08-26 Univ Pisa Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche
CN110845345B (zh) * 2019-11-26 2021-11-09 中国科学院长春应用化学研究所 一种芳香型二胺单体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2708184C3 (de) * 1977-02-25 1980-02-07 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Herstellung von a -Ketocarbonsäureamide!! (A)
DE2733181B2 (de) * 1977-07-22 1979-08-30 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Herstellung von N-substituierten a -Ketocarbonsäureamiden
RU2059603C1 (ru) * 1991-05-09 1996-05-10 Хоффманн-Ля Рош АГ ПРОИЗВОДНЫЕ α -ЗАМЕЩЕННЫХ АРИЛУКСУСНЫХ КИСЛОТ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
HUP9901984A3 (en) * 1995-12-13 2001-01-29 Lilly Co Eli Naphthyl acetamides as spla2 inhibitors, use thereof and pharmaceutical compositions containing these compounds

Also Published As

Publication number Publication date
AU5454498A (en) 1998-06-29
US5916922A (en) 1999-06-29
DE69720034D1 (de) 2003-04-24
DE69720034T2 (de) 2003-12-04
EP0944636B1 (en) 2003-03-19
CA2274019A1 (en) 1998-06-11
KR20000069249A (ko) 2000-11-25
JP2001505882A (ja) 2001-05-08
WO1998024794A1 (en) 1998-06-11
EP0944636A1 (en) 1999-09-29
ATE234850T1 (de) 2003-04-15
EP0944636A4 (en) 2000-07-12
HUP9904218A2 (hu) 2000-05-28
ES2195182T3 (es) 2003-12-01
IL130201A0 (en) 2000-06-01

Similar Documents

Publication Publication Date Title
BR9902365A (pt) Tricìclicos substituìdos
BR9714002A (pt) Pirróis como inibidores de spla2
BR9713261A (pt) Tricìclicos substituìdos
BR9713993A (pt) Pirazóis como inibidores de fosfolipase a2 secretora não pancreática humana
ES2179088T3 (es) Inhibidores de flsa2 1h-indol-3-glioxilamida.
BR9713562A (pt) Fenil glioxamidas como inibidores de spla2
BR9901275A (pt) Triciclicos substituidos.
EP1163208A4 (en) CASPASE INHIBITORS AND THEIR USE
BR9713987A (pt) Fenil acetamidas como inibidores de spla2
ES2159347T3 (es) Naftil-acetamidas como inhibidores de spla2.
EA200401183A1 (ru) Применение ингибиторов il-18 в качестве диагностического маркера
EP1100492A4 (en) SPLA 2 INHIBITORS? INDOLE TYPE
SE9801494D0 (sv) Novel use
ES2174034T3 (es) Naftilglioxamidas como inhibidores de spla2
DE69910432D1 (de) Substituierte pyrroloindole
DE60032774D1 (de) Spla2 inhibitoren
BR9612000A (pt) Naftil glioxamidas como inibidores de spla; &#39;
AU7053700A (en) Novel spla2 inhibitors
BRPI0409691A (pt) compostos de fosfonato tendo atividade imuno-moduladora
ATE329905T1 (de) Tetracyclische derivate als spla2 inhibitoren

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1835 DE 07/03/2006.